Nabriva Therapeutics Plc's

• NBRV's Stock Performance relative to its Competitors

Bioxcel Therapeutics Inc Share Performance -92.54% This Year

Bioxcel Therapeutics Inc Profile BioXcel Therapeutics Inc. is a biopharmaceutical company that operates using an innovative business model. They utilize artificial intelligence (AI) and big data analytics to identify and develop novel therapies for targeted diseases with unmet medical needs. This approach allows them to leverage data-driven insights to expedite drug discovery and development, potentially increasing the efficiency and success rate of their drug candidates. More about Bioxcel Therapeutics Inc 's Market Share

Jaguar Health Inc Share Performance -77.61% This Quarter

Jaguar Health Inc Profile Jaguar Health Inc's business model revolves around developing and commercializing natural, plant-based products for human and animal health. They aim to provide innovative solutions utilizing their scientific expertise in the development of novel medicines and consumer healthcare products. More about Jaguar Health Inc 's Market Share

Scynexis Inc Share Performance +0.19% Over The Past 5 Days

Scynexis Inc Profile Scynexis Inc's business model revolves around the development and commercialization of innovative and effective antifungal therapies. More about Scynexis Inc 's Market Share

Theravance Biopharma inc Share Performance -6.09% This Year

Theravance Biopharma inc Profile Theravance Biopharma Inc's business model focuses on developing and commercializing innovative therapeutics to address unmet medical needs in various therapeutic areas. More about Theravance Biopharma inc 's Market Share

Paratek Pharmaceuticals Inc Share Performance -5.11% One Year

Paratek Pharmaceuticals Inc Profile Paratek Pharmaceuticals Inc is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics. Their business model focuses on identifying and addressing unmet medical needs by developing innovative antibiotics and other pharmaceutical products. They achieve this through their in-house research and development capabilities, strategic partnerships, and collaborations with industry experts. More about Paratek Pharmaceuticals Inc 's Market Share

Sources: Nabriva Therapeutics Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, August 29, 2026 5:22 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nabriva Therapeutics Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.